South Korea plans to invest 2.2 trillion won ($1.9 billion) to become one of the world's five largest COVID-19 vaccine manufacturing bases by 2025, its President Moon Jae-in said on Thursday. The remarks were made at a meeting of a public-private committee created to explore ways to boost vaccine production amid global supply shortages and shipment delays, Moon's office said.
